Olin and Huntsman: HSR waiting period expires for proposed merger

Key highlights
  • The Hart‑Scott‑Rodino Act waiting period for the proposed merger has expired, satisfying one key closing condition.
  • Shareholders of both companies overwhelmingly approved the transaction on August 25, 2026.
  • Closing remains subject to customary closing conditions, including receipt of additional regulatory approvals that are underway.
  • The transaction is described as a merger of equals.

HSR waiting period

The waiting period under the U.S. Hart‑Scott‑Rodino Antitrust Improvements Act in connection with the pending merger has expired, which the companies say satisfies one of the key closing conditions to the transaction.

Shareholder approval

As previously announced, shareholders of both companies overwhelmingly approved the transaction on August 25, 2026.

Next steps and risks

The closing of the transaction remains subject to satisfaction of certain customary closing conditions, including receipt of additional regulatory approvals that are currently underway. The communication also contains a detailed cautionary statement on forward‑looking risks and uncertainties that could affect the timing, approvals, anticipated benefits, and completion of the proposed merger.

Source: Huntsman

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

25 August 2026
Olin and Huntsman shareholders approve all‑stock merger to form OlinHuntsman

Transaction cleared overwhelming preliminary shareholder votes; remains subject to regulatory approvals, certification and other customary closing conditions with closing targeted H1 2027.

30 July 2026
Huntsman Q2 2026 results and Olin merger update

Q2 net loss $6M, adjusted EBITDA $120M; free cash flow used $90M; signed all‑stock merger with Olin; stockholder vote Aug 25, 2026.

14 July 2026
Olin and Huntsman: SEC Declares S‑4 Effective for Planned Merger

SEC declared the Form S‑4 effective; special shareholder meetings set for Aug 25; closing expected H1 2027; transaction targets >$400M in synergies and broader vertical integration.

16 June 2026
Olin and Huntsman to merge as OlinHuntsman

All-stock merger creates an integrated North American chemicals platform with vertical chlorine/caustic integration, ~$12.5B pro forma revenue and $400M+ identified synergies.